A new research paper was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.”
FDA finalizes guidance on cybersecurity for medical devices
Dive Brief: The Food and Drug Administration has finalized guidance intended to help device developers comply with recently enacted cybersecurity obligations for premarket submissions. In
September 27, 2023